Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel 150 mg/day versus 75 mg/day after primary PCI in ST-elevation myocardial infarction
2007-002664-10Phase 2Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of clopidogrel in myocardial infarction (MI) (2 arms), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Maximal platelet aggregation at 30 days. Started Jun 2007; status: completed.
02
Drugs
clopidogrel
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2007-002664-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002664-10.